Terms: = Breast cancer AND SPECC1, FLJ36955, CYTSB, 92521, ENSG00000128487, Q5M775, NSP, HCMOGT-1
36 results:
1. Interference of the Circular RNA Sperm Antigen With Calponin Homology and Coiled-Coil Domains 1 Suppresses Growth and Promotes Apoptosis of breast cancer Cells Partially Through Targeting miR-1236-3p/Chromobox 8 Pathway.
Zhang C; Wang J; Wang H; Li J
Clin Breast Cancer; 2024 Apr; 24(3):e138-e151.e2. PubMed ID: 38341369
[TBL] [Abstract] [Full Text] [Related]
2. Identification of key tumor stroma-associated transcriptional signatures correlated with survival prognosis and tumor progression in breast cancer.
Uddin MN; Wang X
Breast Cancer; 2022 May; 29(3):541-561. PubMed ID: 35020130
[TBL] [Abstract] [Full Text] [Related]
3. Preparation and Comparison of Oral Bioavailability for Different Nano-formulations of Olaparib.
Pathade AD; Kommineni N; Bulbake U; Thummar MM; Samanthula G; Khan W
AAPS PharmSciTech; 2019 Aug; 20(7):276. PubMed ID: 31388783
[TBL] [Abstract] [Full Text] [Related]
4. breast cancer screening: Impact on care pathways.
Lefeuvre D; Catajar N; Le Bihan Benjamin C; Ifrah N; De Bels F; Viguier J; Bousquet PJ
Cancer Med; 2019 Jul; 8(8):4070-4078. PubMed ID: 31172693
[TBL] [Abstract] [Full Text] [Related]
5. The antibacterial and anticancer properties of zinc oxide coated iron oxide nanotextured composites.
Jana TK; Jana SK; Kumar A; De K; Maiti R; Mandal AK; Chatterjee T; Chatterjee BK; Chakrabarti P; Chatterjee K
Colloids Surf B Biointerfaces; 2019 May; 177():512-519. PubMed ID: 30818244
[TBL] [Abstract] [Full Text] [Related]
6. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract] [Full Text] [Related]
7. Randomized controlled trial of dietary fiber for the prevention of radiation-induced gastrointestinal toxicity during pelvic radiotherapy.
Wedlake L; Shaw C; McNair H; Lalji A; Mohammed K; Klopper T; Allan L; Tait D; Hawkins M; Somaiah N; Lalondrelle S; Taylor A; VanAs N; Stewart A; Essapen S; Gage H; Whelan K; Andreyev HJN
Am J Clin Nutr; 2017 Sep; 106(3):849-857. PubMed ID: 28679552
[No Abstract] [Full Text] [Related]
8. Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes cancer Epithelial cells to mesenchymal stem cells and breast cancer growth.
Das A; Dhar K; Maity G; Sarkar S; Ghosh A; Haque I; Dhar G; Banerjee S; Banerjee SK
Sci Rep; 2017 Apr; 7(1):1220. PubMed ID: 28450698
[TBL] [Abstract] [Full Text] [Related]
9. High Level of Radiation-Induced Heat Shock Protein with a Molecular Weight of 27 and 70 kDa is the Hallmark of Radioresistant SP Cells of MCF-7 breast cancer Culture.
Matchuk ON; Zamulaeva IA
Radiats Biol Radioecol; 2016 Jul; 56(4):382-388. PubMed ID: 30703297
[TBL] [Abstract] [Full Text] [Related]
10. Human enhancer of filamentation 1-induced colorectal cancer cell migration: Role of serine phosphorylation and interaction with the breast cancer anti-estrogen resistance 3 protein.
Ibrahim R; Lemoine A; Bertoglio J; Raingeaud J
Int J Biochem Cell Biol; 2015 Jul; 64():45-57. PubMed ID: 25817040
[TBL] [Abstract] [Full Text] [Related]
11. Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells.
Ke XY; Lin Ng VW; Gao SJ; Tong YW; Hedrick JL; Yang YY
Biomaterials; 2014 Jan; 35(3):1096-108. PubMed ID: 24183698
[TBL] [Abstract] [Full Text] [Related]
12. Functionalized nanospheres for targeted delivery of paclitaxel.
Bushman J; Vaughan A; Sheihet L; Zhang Z; Costache M; Kohn J
J Control Release; 2013 Nov; 171(3):315-21. PubMed ID: 23792807
[TBL] [Abstract] [Full Text] [Related]
13. miR-125b regulates side population in breast cancer and confers a chemoresistant phenotype.
Wang HJ; Guo YQ; Tan G; Dong L; Cheng L; Li KJ; Wang ZY; Luo HF
J Cell Biochem; 2013 Oct; 114(10):2248-57. PubMed ID: 23606360
[TBL] [Abstract] [Full Text] [Related]
14. Let-7: a regulator of the ERĪ± signaling pathway in human breast tumors and breast cancer stem cells.
Sun X; Qin S; Fan C; Xu C; Du N; Ren H
Oncol Rep; 2013 May; 29(5):2079-87. PubMed ID: 23467929
[TBL] [Abstract] [Full Text] [Related]
15. [Role of let-7 in maintaining characteristics of breast cancer stem cells].
Sun X; Fan C; Hu LJ; Du N; Xu CW; Ren H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Aug; 28(8):789-92. PubMed ID: 22863580
[TBL] [Abstract] [Full Text] [Related]
16. Safety and cost-effectiveness of shortening hospital follow-up after breast cancer treatment.
Lu W; Greuter MJ; Schaapveld M; Vermeulen KM; Wiggers T; de Bock GH
Br J Surg; 2012 Sep; 99(9):1227-33. PubMed ID: 22828861
[TBL] [Abstract] [Full Text] [Related]
17. breast cancer anti-estrogen resistance 3 (BCAR3) protein augments binding of the c-Src SH3 domain to Crk-associated substrate (p130cas).
Makkinje A; Vanden Borre P; Near RI; Patel PS; Lerner A
J Biol Chem; 2012 Aug; 287(33):27703-14. PubMed ID: 22711540
[TBL] [Abstract] [Full Text] [Related]
18. breast cancer, side population cells and ABCG2 expression.
Britton KM; Eyre R; Harvey IJ; Stemke-Hale K; Browell D; Lennard TWJ; Meeson AP
Cancer Lett; 2012 Oct; 323(1):97-105. PubMed ID: 22521545
[TBL] [Abstract] [Full Text] [Related]
19. Paclitaxel in tyrosine-derived nanospheres as a potential anti-cancer agent: in vivo evaluation of toxicity and efficacy in comparison with paclitaxel in Cremophor.
Sheihet L; Garbuzenko OB; Bushman J; Gounder MK; Minko T; Kohn J
Eur J Pharm Sci; 2012 Feb; 45(3):320-9. PubMed ID: 22155544
[TBL] [Abstract] [Full Text] [Related]
20. Side population in MDA-MB-231 human breast cancer cells exhibits cancer stem cell-like properties without higher bone-metastatic potential.
Hiraga T; Ito S; Nakamura H
Oncol Rep; 2011 Jan; 25(1):289-96. PubMed ID: 21109989
[TBL] [Abstract] [Full Text] [Related]
[Next]
